SecurityCRSP / CRISPR Therapeutics AG (H17182108)
Institutional Owners137
Institutional Shares17,852,571 - 37.83%
Common Shares Outstanding47,186,829 shares (as of 2018-03-31)
Institutional Value$ 212,708,986,000 USD

Institutional Stock Ownership and Shareholders()

CRSP / CRISPR Therapeutics AG Institutional Ownership

CRISPR Therapeutics AG (NASDAQ:CRSP) has 137 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17,852,571 shares. Largest shareholders include Versant Venture Management, LLC, NEA Management Company, LLC, Abingworth LLP, Wellington Management Group LLP, Franklin Resources Inc, Farallon Capital Management Llc, New Leaf Venture Partners, L.L.C., BlackRock Inc., Clough Capital Partners L P, and Marshall Wace North America L.P..
CRISPR Therapeutics AG (NASDAQ:CRSP) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/crsp"><img src="https://images.fintel.io/us-crsp-so.png" alt="CRSP / CRISPR Therapeutics AG Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-09 13F-HR NORTHERN TRUST CORP 15,880 726
2018-04-30 13F-HR BOSTON FAMILY OFFICE LLC 10,000 457
2018-05-14 13F-HR Tekla Capital Management LLC 141,191 6,454
2018-05-11 13F-HR CITIGROUP INC 1,305 1,322 1.30 30 61 103.33
2018-05-09 13F-HR Glen Harbor Capital Management LLC 640 29
2018-05-15 13F-HR Marshall Wace LLP 4,627 212
2018-04-26 13F-HR SIMPLEX TRADING, LLC 2,768 20,015 623.09 64 914 1,328.13
2018-05-15 13F-HR Paloma Partners Management Co 12,360 0 -100.00 290 0 -100.00
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 0 2,532 0 116
2018-04-23 13F-HR Financial Architects, Inc 1,000 46
2018-04-26 13F-HR ESSEX INVESTMENT MANAGEMENT CO LLC 51,080 21,790 -57.34 1,199 996 -16.93
2018-05-14 13F-HR Wealthcare Advisory Partners LLC 16 1
2018-05-15 13F-HR ACUTA CAPITAL PARTNERS, LLC Call 80,000 0 -100.00 1,878 0 -100.00
2018-05-11 13F-HR GSA CAPITAL PARTNERS LLP 80,600 18,831 -76.64 1,892 861 -54.49
2018-04-12 13F-HR Valeo Financial Advisors, Llc 130 105 -19.23 3 5 66.67
2018-04-06 13F-HR Carroll Financial Associates, Inc. 450 450 0.00 10 20 100.00
2018-05-15 13F-HR Nicholas Investment Partners, LP 80,490 3,679
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 44,733 92,583 106.97 2,045 5,440 166.01
2018-05-15 13F-HR Bank of New York Mellon Corp 0 21,778 0 995
2018-05-11 13F-HR Cutler Group LP Call 2,900 3,300 13.79 12 38 216.67
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 8,584 9,691 12.90 202 443 119.31
2018-05-10 13F-HR FRANKLIN RESOURCES INC 794,533 711,733 -10.42 18,656 32,534 74.39
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 45,974 104,798 127.95 1,079 4,790 343.93
2018-05-15 13F-HR ELEMENT CAPITAL MANAGEMENT LLC 4,587 210
2018-07-17 13F-HR Winslow, Evans & Crocker, Inc. 500 30
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 95,130 0 -100.00 2,234 0 -100.00
2018-05-11 13F-HR SEI INVESTMENTS CO 800 37
2018-05-03 13F-HR Trexquant Investment LP 18,285 11,410 -37.60 429 522 21.68
2018-05-15 13F-HR DRIEHAUS CAPITAL MANAGEMENT LLC 4,800 219
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Put 80,500 3,680
2018-05-10 13F-HR Spark Investment Management LLC 0 13,200 0 603
2018-05-15 13F-HR FARALLON CAPITAL MANAGEMENT LLC 858,602 645,000 -24.88 20,160 29,483 46.25
2018-05-14 13F-HR UNITED SERVICES AUTOMOBILE ASSOCIATION 43,700 26,400 -39.59 1,026 1,207 17.64
2018-05-15 13F-HR BARCLAYS PLC Call 34,700 1,586
2018-07-17 13F-HR FOX RUN MANAGEMENT, L.L.C. 11,347 667
2018-04-18 13F-HR Creative Planning 10,370 0 -100.00 243 0 -100.00
2018-05-04 13F-HR VICTORY CAPITAL MANAGEMENT INC 42,670 1,950
2018-05-15 13F-HR A.R.T. Advisors, LLC 24,455 20,655 -15.54 574 944 64.46
2018-05-14 13F-HR Mosaic Family Wealth, LLC 495 495 0.00 12 23 91.67
2018-05-15 13F-HR We Are One Seven, Llc 2,000 2,000 0.00 47 91 93.62
2018-05-14 13F-HR BlueMountain Capital Management, LLC 3,475 159
2018-04-20 13F-HR Steward Partners Investment Advisory, Llc 100 4
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 25,106 11,131 -55.66 589 509 -13.58
2018-05-23 13F-HR/A Allianz Asset Management AG 232,060 232,744 0.29 5,449 10,639 95.25
2018-05-14 13F-HR Gryphon Financial Partners Llc 50 75 50.00 1 3 200.00
2018-05-11 13F-HR CITADEL ADVISORS LLC 53,696 2,454
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 13,869 26,620 91.94 325 1,217 274.46
2018-05-15 13F-HR Marshall Wace North America L.P. 476,762 21,793
2017-10-26 13F-HR PRIVATE CAPITAL MANAGEMENT INC 5,000 0 -100.00 80 0 -100.00
2018-05-15 13F-HR CLOUGH CAPITAL PARTNERS L P 890,631 560,231 -37.10 20,912 25,608 22.46
2018-05-14 13F-HR ProShare Advisors LLC 22,100 21,277 -3.72 519 973 87.48
2018-05-15 13F-HR Krasney Financial LLC 210 10
2018-05-10 13F-HR Flinton Capital Management LLC 1,120 51
2018-05-10 13F-HR Stratos Wealth Partners, LTD. 465 21
2018-05-15 13F-HR Advisor Group, Inc. 1,100 1,194 8.55 26 55 111.54
2018-05-15 13F-HR JANE STREET GROUP, LLC 19,373 886
2018-05-10 13F-HR NEA Management Company, LLC 3,220,728 3,484,464 8.19 75,623 159,275 110.62
2018-05-14 13F-HR ARK Investment Management LLC 31,388 72,534 131.09 737 3,316 349.93
2018-05-15 13F-HR Hilltop Holdings Inc. 20,109 919
2018-05-15 13F-HR Squarepoint Ops LLC 7,919 362
2018-05-04 13F-HR CAPITAL ADVISORS INC/OK 149,704 148,917 -0.53 3,515 6,807 93.66
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 27,133 1,171
2018-05-15 13F-HR D. E. Shaw & Co., Inc. 15,995 731
2018-04-12 13F-HR Ipswich Investment Management Co., Inc. 48,257 57,075 18.27 1,133 2,609 130.27
2018-04-30 13F-HR Capital Investment Advisory Services, LLC 10,300 14,160 37.48 242 647 167.36
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 22,672 27,562 21.57 532 1,260 136.84
2018-05-15 13F-HR BARCLAYS PLC Put 22,200 1,015
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 58,900 457,100 676.06 1,383 20,894 1,410.77
2018-05-10 13F-HR Tortoise Investment Management, LLC 1,000 46
2018-05-15 13F-HR ORBIMED ADVISORS LLC 0 104,401 0 4,772
2018-04-16 13F-HR Westside Investment Management, Inc. 100 0 -100.00 2,607 0 -100.00
2018-05-15 13F-HR MORGENS WATERFALL VINTIADIS & CO INC 30,000 10,000 -66.67 704 457 -35.09
2018-05-03 13F-HR Zurcher Kantonalbank (Zurich Cantonalbank) 5,300 1,700 -67.92 124 78 -37.10
2018-05-07 13F-HR BRADLEY FOSTER & SARGENT INC/CT 11,765 0 -100.00 276 0 -100.00
2018-04-17 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 100 100 0.00 2 5 150.00
2018-05-04 13F-HR D'Orazio & Associates, Inc. 132 132 0.00 3 6 100.00
2017-11-09 13F-HR Ark Investment Management Llc 25,555 457
2018-04-25 13F-HR TOTH FINANCIAL ADVISORY CORP 100 5
2018-05-14 13F-HR Castle Rock Wealth Management, Llc 8,420 385
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 1,261 14,193 1,025.54 30 649 2,063.33
2018-05-08 13F-HR SIGNATUREFD, LLC 1,050 48
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 10,029 7,435 -25.86 235 340 44.68
2018-05-11 13F-HR MACQUARIE GROUP LTD 600 0 -100.00 14 0 -100.00
2018-05-15 13F-HR New Leaf Venture Partners, L.L.C. 507,730 595,642 17.31 11,922 27,227 128.38
2018-05-15 13F-HR UBS Group AG 2,370 59,395 2,406.12 56 2,715 4,748.21
2018-05-02 13F-HR Daiwa Securities Group Inc. 254 12
2018-05-10 13F-HR JP Morgan Chase & Co 107,444 0 -100.00 2,523 0 -100.00
2018-05-09 13F-HR BBR PARTNERS, LLC 5,000 229
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 21,517 461,377 2,044.24 505 21,089 4,076.04
2018-05-08 13F-HR Neuburgh Advisers LLC 1,360 62
2018-05-15 13F-HR VANGUARD GROUP INC 17,268 41,344 139.43 405 1,890 366.67
2018-05-11 13F-HR Cutler Group LP Put 2,000 7,700 285.00 0 15
2018-05-15 13F-HR Aevitas Wealth Management, Inc. 28,591 6,846 -76.06 671 313 -53.35
2018-05-11 13F-HR Covington Capital Management 200 375 87.50 5 17 240.00
2018-05-11 13F-HR CITADEL ADVISORS LLC Call 22,100 1,010
2018-05-14 13F-HR IHT Wealth Management, LLC 5,501 5,551 0.91 143 240 67.83
2018-05-15 13F-HR Wellington Management Group LLP 0 919,514 0 42,031
2018-05-15 13F-HR BARCLAYS PLC 15,300 15,700 2.61 360 717 99.17
2018-05-11 13F-HR Cutler Group LP 0 6,097 0 278
2018-05-15 13F-HR PIONEER INVESTMENT MANAGEMENT INC 3,200 2,800 -12.50 75 128 70.67
2018-05-14 13F-HR Virtu Financial LLC 5,352 245
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 30,601 157,190 413.68 719 7,185 899.30
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 39,811 53,696 34.88 935 2,454 162.46
2018-05-09 13F-HR BlackRock Inc. 552,558 572,218 3.56 12,974 26,156 101.60
2018-05-14 13F-HR MORGAN STANLEY 88,806 96,620 8.80 2,085 4,417 111.85
2018-05-14 13F-HR AXIOM INTERNATIONAL INVESTORS LLC /DE 35,688 1,631
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 34,400 1,572
2018-07-13 13F-HR Versant Venture Management, LLC 4,606,242 3,608,874 -21.65 210,551,322 212,057,436 0.72
2018-05-15 13F-HR Ghost Tree Capital, LLC 150,000 0 -100.00 3,522 0 -100.00
2018-05-15 13F-HR LPL Financial LLC 5,610 256
2018-05-14 13F-HR TOCQUEVILLE ASSET MANAGEMENT L.P. 6,500 297
2018-05-08 13F-HR RIVERHEAD CAPITAL MANAGEMENT LLC 1,000 46
2018-05-03 13F-HR HUDSON CANYON INVESTMENT COUNSELORS LLC 2,000 91
2018-05-02 13F-HR THOMPSON DAVIS & CO., INC. 125 450 260.00 3 21 600.00
2018-05-14 13F-HR Commonwealth Equity Services, Llc. 5,773 263
2018-04-23 13F-HR Advisory Services Network, LLC 0 995 0 45
2018-05-11 13F-HR CITADEL ADVISORS LLC Put 80,500 3,680
2018-05-15 13F-HR BLAIR WILLIAM & CO/IL 0 15,500 0 709
2018-04-20 13F-HR Seacrest Wealth Management, Llc 900 41
2018-05-15 13F-HR CREDIT SUISSE AG/ 442,845 447,048 0.95 10,398 20,435 96.53
2018-05-15 13F-HR Vivo Capital, LLC 98,511 0 -100.00 2,313 0 -100.00
2018-05-14 13F-HR Opaleye Management Inc. 281,000 0 -100.00 6,597 0 -100.00
2018-05-14 13F-HR GRANAHAN INVESTMENT MANAGEMENT INC/MA 141,140 86,743 -38.54 3,314 3,965 19.64
2018-04-20 13F-HR LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA 600 600 0.00 14 27 92.86
2018-04-19 13F-HR Cribstone Capital Management, LLC 90 111 23.33 2 5 150.00
2018-05-10 13F-HR DUBUQUE BANK & TRUST CO 1,425 1,425 0.00 33 65 96.97
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 934 4,054 334.05 22 186 745.45
2018-05-17 13F-HR Atlantic Trust Group, LLC 525 24
2018-05-15 13F-HR Novo A/S 223,317 223,317 0.00 5,243 10,208 94.70
2018-05-11 13F-HR AllSquare Wealth Management LLC 60 30 -50.00 1 1 0.00
2018-05-11 13F-HR Quantbot Technologies LP 1,417 64
2018-05-10 13F-HR Artal Group S.A. 50,000 25,000 -50.00 1,174 1,143 -2.64
2018-06-04 13F-HR Eam Global Investors Llc 23,820 1,089
2018-04-30 13F-HR Global Thematic Partners, LLC 633,452 351,540 -44.50 14,873 16,069 8.04
2018-05-14 13F-HR COURAGE CAPITAL MANAGEMENT LLC 8,100 8,100 0.00 190 370 94.74
2018-05-15 13F-HR TUDOR INVESTMENT CORP ET AL 8,608 393
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Call 22,100 1,010
2018-04-19 13F-HR SeaBridge Investment Advisors LLC 300 14
2018-02-15 13F-HR Bb&t Investment Services, Inc. 1,000 1,000 0.00 18 23 27.78
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 111 5
2018-05-15 13F-HR Abingworth LLP 1,951,359 1,887,202 -3.29 45,798 86,207 88.23
2018-05-04 13F-HR M&T BANK CORP 4,430 202
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 82,838 82,331 -0.61 1,945 3,763 93.47
2018-05-09 13F-HR IFP Advisors, Inc 400 325 -18.75 9 15 66.67
2018-05-07 13F-HR Focused Wealth Management, Inc 200 9
2018-05-14 13F-HR BOKF, NA 4,630 212
2018-05-15 13F-HR DEUTSCHE BANK AG\ 58,265 18,854 -67.64 1,367 860 -37.09
2018-05-04 13F-HR D.A. DAVIDSON & CO. 15,752 15,252 -3.17 370 697 88.38
2018-05-15 13F-HR Krilogy Financial LLC 300 200 -33.33 7 9 28.57
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 56,400 100,700 78.55 1,324 4,603 247.66
2018-05-14 13F-HR Patriot Financial Group Insurance Agency, LLC 4,890 34,107 597.48 127 1,476 1,062.20
2018-05-18 13F-HR CIBC World Markets Inc. 25,298 1,156
2018-05-15 13F-HR Casdin Capital, LLC 135,000 6,171
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 26,988 27,513 1.95 633 1,257 98.58
2018-04-30 13F-HR K.J. Harrison & Partners Inc 23,525 0 -100.00 552 0 -100.00
2018-07-13 13F-HR HARTWELL J M LIMITED PARTNERSHIP 5,000 5,000 0.00 229 294 28.38
2018-05-11 13F-HR Russell Investments Group, Ltd. 101,188 0 -100.00 2,147 0 -100.00
2018-05-15 13F-HR HBK Sorce Advisory LLC 4,911 224
2018-05-08 13F-HR Tyers Asset Management LLC 880 40
2018-05-15 13F-HR Capital World Investors 138,000 6,308
2018-05-15 13F-HR ACUTA CAPITAL PARTNERS, LLC Put 10,000 457
2018-05-11 13F-HR First Allied Advisory Services, Inc. 58,905 2,695

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

11h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

13h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

New Study Says DNA Damage From CRISPR-Cas9 Gene-Editing Has Been Underestimated

12h biospace
Shares of CRISPR Therapeutics (-8 percent), Editas Medicine (-5 percent) and Intellia Therapeutics (-6.7 percent) are all plunging following the release of a report that claimed CRISPR-Cas9 gene editing may cause some dangerous side effects. (6-0)

A Single Study Is No Reason to Sell Crispr Stock | InvestorPlace

21h investorplace
Crispr Therapeutics (NASDAQ:CRSP) is down on Monday after an article in today’s issue of Nature (one of the most-trusted, well-known scientific journals) raised concerns about Crispr’s gene-editing technology. As of this writing, Crispr stock is down 7.9%. (0-1)

UPDATE 1-CRISPR gene editing can cause risky collateral DNA damage - study

23h reuters
LONDON (Reuters) - Scientists studying the effects of the potentially game-changing gene editing tool CRISPR/Cas9 have found it can cause unexpected genetic damage which could lead to dangerous changes in some cells. (6-1)

Arcadia Biosciences:  A Speculative Pure-Play In The Genome Editing Agricultural Space

2018-07-16 seekingalpha
I highlight a number of reasons why I've taken a speculative position in RKDA, including commercialization prospects and cash on hand relative to historical burn rates. (5-2)

5 Big Pharma Stocks Investors Love Right Now

2018-07-13 investorplace
Solid clinical results for Biogen (NASDAQ:BIIB) sent the stock up nearly 20% in a single day last week. That set the tone for a number of hot drug stock picks for July. (42-3)

CUSIP: H17182108